Biotech

All Articles

FibroGen lays off 75% of US team as possession flunks 2 even more tests

.FibroGen is drastically reorganizing its own business, laying off 75% of its U.S. personnel and qui...

Tracon unwind full weeks after injectable PD-L1 inhibitor fail

.Tracon Pharmaceuticals has made a decision to wane procedures weeks after an injectable immune syst...

Ideaya bags possibility on Biocytogen bispecific ADC in $400M deal

.Ideaya Biosciences is wagering $400 million in biobucks that a bispecific antibody-drug conjugate (...

Takeda takes $140M reduction on failed epilepsy drug, boasts FDA operate

.We currently know that Takeda is actually wanting to locate a path to the FDA for epilepsy medicati...

VBI Injections declare bankruptcy, seeks asset sale

.Immunology biotech VBI Vaccines is actually drifting dangerously close to the climax, along with pl...

Celldex anti-cKIT antibody minimize hives in another phase 2 research

.It is actually difficult to muscle in on an area as reasonable as immunology, but Celldex Rehabs st...

Boehringer provides to $1.3 B for checkpoint prevention biotech

.Boehringer Ingelheim is actually offering up to $1.3 billion for Nerio Therapeutics and also a prec...

Ventyx's last resort for inflamed med sides in Crohn's failure

.Ventyx Biosciences' Crohn's condition medication performed not assist individuals attain remission ...

Cognition's stage 2 SHINE information blemish Alzheimer's possibility

.Cognition Therapeutics' phase 2 sparkle trial has actually taken a number of the radiance off the A...

BMS centers bispecific months after submitting to operate phase 3 test

.Bristol Myers Squibb has actually had a whiplash change of mind on its BCMA bispecific T-cell engag...